David Scott Miller
AuthID: R-00K-250
1
TÃTULO: Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial
AUTORES: Jung-Min Lee; Austin Miller; Peter G Rose; Mariam AlHilli; Christina Washington; Veena S John; Chirag A Shah; Koji Matsuo; Jean Siedel; David Scott Miller; Elizabeth E Hopp; Andrea O’Shea; John K Chan; Leslie S Bradford; Christopher B Morse; Christa I Nagel; Kerry J Rodabaugh; Elise C Kohn; Kathleen N Moore; Joyce F Liu;
PUBLICAÇÃO: 2025, FONTE: Clinical Cancer Research
AUTORES: Jung-Min Lee; Austin Miller; Peter G Rose; Mariam AlHilli; Christina Washington; Veena S John; Chirag A Shah; Koji Matsuo; Jean Siedel; David Scott Miller; Elizabeth E Hopp; Andrea O’Shea; John K Chan; Leslie S Bradford; Christopher B Morse; Christa I Nagel; Kerry J Rodabaugh; Elise C Kohn; Kathleen N Moore; Joyce F Liu;
PUBLICAÇÃO: 2025, FONTE: Clinical Cancer Research
